← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Prediction Sciences, Llc
La Jolla, CA
$5,315,246
Total funding
12
Grants
Funding over time
peak $1.4M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$3,668,683 · 7
NSF$1,646,563 · 5
By mechanism
R44$2,524,349 · 2
—$1,646,563 · 5
R43$1,144,334 · 5
Investigators at Prediction Sciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
GeneRx - colorectal cancer recurrence prediction$882,531
R44 · FY2007 · CA
SBIR Phase II: Multi-Marker Prognostic Test for Breast Cancer Outcome$847,480
· FY2008 · TIP
Development of Stroke Point of Care Immunoassay for Cellular Fibronectin$749,929
R44 · FY2009 · NS
Development of Stroke Point of Care Immunoassay for Cellular Fibronectin$601,973
R44 · FY2010 · NS
SBIR Phase II: Hypertension Treatment Responder Prediction$500,000
· FY2002 · TIP
GeneRx - colorectal cancer recurrence prediction$289,916
R44 · FY2008 · CA
Biomarker panel to differentiate stroke from stroke mimic$252,533
R43 · FY2008 · NS
SNP-based lithium treatment outcome diagnostic$242,805
R43 · FY2007 · MH
SNP-based lithium treatment outcome diagnostic$242,805
R43 · FY2006 · MH
c-FN as a predictor of hemorrhagic transformation in t-PA treated stroke patients$206,191
R43 · FY2007 · NS
Pharmacogenetic Prediction of Paroxetine Response$100,000
R43 · FY2002 · MH
SBIR Phase I: Pharmacogenomic Depression Treatment Prediction$100,000
· FY2002 · TIP
GeneRx - colorectal cancer recurrence prediction$100,000
R43 · FY2005 · CA
SBIR Phase I: Multi-Marker Prognostic Test for Breast Cancer Outcome$99,894
· FY2006 · TIP
SBIR Phase I: Hypertension Treatment Responder Prediction$99,189
· FY2001 · TIP